MarketCap
Facebook
X
TelegramQuarterly report 2025-Q3
added 11-10-2025
Health Catalyst Book Value 2011-2026 | HCAT
Book value is a financial metric that reflects the value of a company's assets minus its liabilities as of a specific date, according to accounting records. In simple terms, it is the amount that would remain for the owners of the company if all assets were sold and all debts paid off.What is included in book value
- Assets — all company resources: real estate, equipment, inventory, cash, accounts receivable, and others.
- Liabilities — all debts and financial obligations: loans, accounts payable, taxes, and other obligations.
- Assessment of the company's "real" value
Book value shows how much the company is worth according to accounting data, that is, the value of its property taking debts into account. - Comparison with market capitalization
Comparing book value and the market price of shares helps to understand whether the company is overvalued or undervalued by the market. - Indicator of financial stability
If the book value is high, it indicates the company has significant assets, which reduces risks for investors. - Key component for financial ratios
Many metrics, such as the price-to-book ratio (P/B), use book value to analyze the attractiveness of shares.
Annual Book Value Health Catalyst
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 365 M | 367 M | 425 M | 522 M | 276 M | 201 M | -375 M | -259 M | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 522 M | -375 M | 190 M |
Quarterly Book Value Health Catalyst
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q3 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 332 M | 348 M | 377 M | 365 M | - | - | - | 382 M | 425 M | - | - | 481 M | 522 M | 549 M | 276 M | 269 M | 276 M | 276 M | 276 M | 276 M | 201 M | 201 M | 201 M | 201 M | 35.1 M | 35.1 M | 35.1 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 549 M | 35.1 M | 288 M |
Book Value of other stocks in the Health information services industry
| Issuer | Book Value | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Accolade
ACCD
|
391 M | - | 0.29 % | $ 206 M |  USA |
 |
Cerner Corporation
CERN
|
3.68 B | - | - | $ 27.9 B | USA |
 |
Computer Programs and Systems
CPSI
|
187 M | - | 4.4 % | $ 133 M | USA |
 |
Covetrus
CVET
|
1.53 B | - | - | $ 2.94 B | USA |
 |
Castlight Health, Inc.
CSLT
|
7.25 B | - | -7.28 % | $ 227 M | USA |
 |
HMS Holdings Corp.
HMSY
|
715 M | - | - | $ 3.29 B | USA |
 |
Inovalon Holdings, Inc.
INOV
|
26.4 M | - | - | $ 6.37 B | USA |
 |
iCAD
ICAD
|
28.7 M | - | - | $ 102 M | USA |
 |
1Life Healthcare
ONEM
|
1.73 B | - | - | $ 3.37 B | USA |
 |
Akerna Corp.
KERN
|
-7.01 M | - | - | $ 161 M | USA |
 |
HealthStream
HSTM
|
511 M | $ 22.03 | 1.52 % | $ 669 M | USA |
 |
Allscripts Healthcare Solutions
MDRX
|
1.41 B | - | -10.39 % | $ 886 M | USA |
 |
American Well Corporation
AMWL
|
248 M | $ 5.56 | 7.96 % | $ 89.2 M | USA |
 |
Evolent Health
EVH
|
859 M | $ 3.55 | 1.28 % | $ 333 M | USA |
 |
HealthEquity
HQY
|
2.04 B | $ 81.45 | 1.27 % | $ 6.97 B | USA |
 |
MTBC
MTBC
|
49.8 M | - | -0.58 % | $ 51.7 M | USA |
 |
Change Healthcare
CHNG
|
3.28 B | - | - | $ 9.03 B | USA |
 |
Omnicell
OMCL
|
1.24 B | $ 41.51 | 1.73 % | $ 1.91 B | USA |
 |
GoodRx Holdings
GDRX
|
725 M | $ 2.19 | 5.8 % | $ 845 M | USA |
 |
Progyny
PGNY
|
422 M | $ 17.95 | 2.43 % | $ 1.54 B | USA |
 |
Premier
PINC
|
1.53 B | - | - | $ 2.33 B | USA |
 |
So-Young International
SY
|
1.96 B | $ 2.89 | 3.96 % | $ 229 M |  China |
 |
R1 RCM
RCM
|
347 M | - | - | $ 3.81 B | USA |
 |
NantHealth
NH
|
-225 M | - | -46.64 % | $ 10.4 M | USA |
 |
OptimizeRx Corporation
OPRX
|
127 M | $ 7.94 | 8.47 % | $ 136 M | USA |
 |
NextGen Healthcare
NXGN
|
432 M | - | - | $ 1.6 B | USA |
 |
Phreesia
PHR
|
251 M | $ 12.67 | 2.34 % | $ 691 M | USA |
 |
Schrödinger
SDGR
|
364 M | $ 13.17 | 5.32 % | $ 967 M | USA |
 |
Zhongchao
ZCMD
|
24.2 M | $ 1.69 | -1.98 % | $ 8.8 M | China |
 |
Signify Health
SGFY
|
821 M | - | -0.02 % | $ 7.21 B | USA |
 |
Teladoc Health
TDOC
|
1.39 B | $ 5.2 | 1.76 % | $ 916 M | USA |
 |
Streamline Health Solutions
STRM
|
12.3 M | - | - | $ 21.4 M | USA |
 |
10x Genomics
TXG
|
741 M | $ 22.46 | -0.73 % | $ 2.63 B | USA |
 |
Tabula Rasa HealthCare
TRHC
|
-57 M | - | - | $ 255 M | USA |
 |
Veeva Systems
VEEV
|
4.64 B | $ 188.53 | 1.38 % | $ 30.3 B | USA |
 |
SCWorx Corp.
WORX
|
4.49 M | $ 0.14 | -19.22 % | $ 204 K | USA |